DESCRIPTION (provided by applicant): The long-term goal of this product development plan is to develop a recombinant bacille Calmette-Gu rin (rBCG) strain that displays reduced toxicity and improved ...SBIR Phase I 2007 Department of Health and Human Services
| BACILLIGEN, INC.
9700 GREAT SENECA HIGHWAY
ROCKVILLE, MD, 20850 3307
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||n/a|